Provided by Tiger Fintech (Singapore) Pte. Ltd.

SILO PHARMA INC.

0.6663
+0.00590.89%
Post-market: 0.6600-0.0063-0.95%19:46 EDT
Volume:199.74K
Turnover:133.08K
Market Cap:4.80M
PE:-0.59
High:0.6840
Open:0.6745
Low:0.6600
Close:0.6604
Loading ...
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jul 27, 2024

Correspondence

Form CORRESP - Correspondence
Jul 25, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 05, 2024

Major Issues Report

Form 8-K - Current report
Mar 25, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Jan 27, 2024

Correspondence

Form CORRESP - Correspondence
Jan 26, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 12, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jan 09, 2024

Major Issues Report

Form 8-K - Current report
Dec 11, 2023

Major Issues Report

Form 8-K - Current report